Concept Richtlijn Erfelijke darmkanker 2007 versie 7 - Oncoline

14. Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA.Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer2006;94:814-819.15. Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginalultrasound monitoring in high-risk women cannot prevent the diagnosis of advancedovarian cancer. Gynecol Oncol 2006;100:20-6.16. Olivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ et al.Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers andevents during follow-up. Br J Cancer 2004;90:1492-7.17. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van 't Veer L, Garber JE et al.Prevention and Observation of Surgical End Points Study Group. Prophylacticoophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22.18. Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, Van der Zee AG. Gynecologicscreening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2003;91:74-80.19. Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J et al. Outcome ofpreventive surgery and screening for breast and ovarian cancer in BRCA mutationcarriers. J Clin Oncol 2002;20:1260-8.20. Schmeler KM, Lynch HT, Chen L-M, Munsell MF, Soliman PT, Clark MB et al.Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch-syndrome. NEngl J Med 2006;354:261-9.21. Stirling D, Evans DG, Pichert G, Shenton A, Kirk EN, Rimmer S et al. Screening forfamilial ovarian cancer: failure of current protocols to detect ovarian cancer at an earlystage according to the international Federation of gynecology and obstetrics system. JClin Oncol 2005;23:5588-96.22. Vasen HF, Tesfay E, Boonstra H, Mourits MJ, Rutgers E, Verheyen R et al. Earlydetection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer2005;41:549-54.Concept landelijke richtlijn erfelijke darmkanker versie 7 d.d. 7 november 2007.77